Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Irinotecan 6Cyclophosphamide 5Carboplatin 3temsirolimus 2Sirolimus 2Filgrastim 2Early Intervention, Educational 2sargramostim 1reolysin 1irofulven 1etoposide phosphate 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Thalidomide 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Immunohistochemistry 1Genetic Testing 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unspecified Childhood Solid Tumor, Protocol Specific × Tirapazamine × Other solid neoplasm × Clear all
NCT00003288 2013-02-05

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡